Max Healthcare Q3 FY26: Revenue up 10% to Rs 2,608 Cr, PAT rises 9% to Rs 344 Cr
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty 100 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare Q3 FY26: Gross revenue up 10% YoY to Rs 2,608 Cr, Operating EBITDA up 4% to Rs 648 Cr, PAT up 9% to Rs 344 Cr (after Rs 55 Cr exceptional items). EBITDA margin fell to 26.1% from 27.3% YoY. For 9M FY26, revenue grew 19% to Rs 7,874 Cr, PAT up 30% to Rs 1,244 Cr. Net debt Rs 2,166 Cr. Signed SPA for 450-bed hospital in Pune. Brownfield beds at Mohali and Nanavati Max delivering 31-39% margins.
Steady Q3 with revenue up 10% and PAT up 9%, but margin dipped to 26.1% from 27.3%. 9M PAT grew 30%. Expansion via Pune acquisition and brownfield beds underway.